BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17374751)

  • 1. Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus.
    Spatz SJ; Petherbridge L; Zhao Y; Nair V
    J Gen Virol; 2007 Apr; 88(Pt 4):1080-1096. PubMed ID: 17374751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
    Spatz SJ; Rue CA
    Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
    Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
    Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.
    Spatz SJ; Silva RF
    Virus Genes; 2007 Aug; 35(1):41-53. PubMed ID: 16964553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines.
    Petherbridge L; Howes K; Baigent SJ; Sacco MA; Evans S; Osterrieder N; Nair V
    J Virol; 2003 Aug; 77(16):8712-8. PubMed ID: 12885890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain.
    Spatz SJ; Rue C; Schumacher D; Osterrieder N
    Virus Genes; 2008 Aug; 37(1):69-80. PubMed ID: 18516669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
    Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
    Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete genome sequence of virulent duck enteritis virus (DEV) strain 2085 and comparison with genome sequences of virulent and attenuated DEV strains.
    Wang J; Höper D; Beer M; Osterrieder N
    Virus Res; 2011 Sep; 160(1-2):316-25. PubMed ID: 21802458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.
    Spatz SJ; Schat KA
    Virus Genes; 2011 Jun; 42(3):331-8. PubMed ID: 21336949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in the meq gene between oncogenic and attenuated strains of Marek's disease virus serotype 1.
    Lee SI; Takagi M; Ohashi K; Sugimoto C; Onuma M
    J Vet Med Sci; 2000 Mar; 62(3):287-92. PubMed ID: 10770601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
    Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
    Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
    Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
    Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A MEQ-deleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine.
    Silva RF; Dunn JR; Cheng HH; Niikura M
    Avian Dis; 2010 Jun; 54(2):862-9. PubMed ID: 20608531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of the protective efficacy of rMd5deltaMeq and CVI988/ Rispens against a vv+ strain of Marek's disease virus infection in a series of recombinant congenic strains of White Leghorn chickens.
    Chang S; Ding Z; Dunn JR; Lee LF; Heidari M; Song J; Ernst CW; Zhang H
    Avian Dis; 2011 Sep; 55(3):384-90. PubMed ID: 22017035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: evidence for splicing of mRNA from a new viral glycoprotein gene.
    Becker Y; Asher Y; Tabor E; Davidson I; Malkinson M
    Virus Genes; 1994 Jan; 8(1):55-69. PubMed ID: 8209423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2.
    Spatz SJ
    Virus Res; 2010 May; 149(2):135-42. PubMed ID: 20109506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative sequence analysis of a highly oncogenic but horizontal spread-defective clone of Marek's disease virus.
    Spatz SJ; Zhao Y; Petherbridge L; Smith LP; Baigent SJ; Nair V
    Virus Genes; 2007 Dec; 35(3):753-66. PubMed ID: 17721813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular evolution of Marek's disease virus (MDV) field strains in a 40-year time period.
    Woźniakowski G; Samorek-SalamonowiczA E
    Avian Dis; 2014 Dec; 58(4):550-7. PubMed ID: 25618999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiological investigation of Marek's disease virus from Guangxi, China.
    Teng LQ; Wei P; Song ZB; He JJ; Cui ZZ
    Arch Virol; 2011 Feb; 156(2):203-6. PubMed ID: 21053030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.